78 related articles for article (PubMed ID: 10659560)
1. The use of the stabilization period in ECT research in schizophrenia: I. A pilot study.
Chanpattana W
J Med Assoc Thai; 1999 Dec; 82(12):1193-9. PubMed ID: 10659560
[TBL] [Abstract][Full Text] [Related]
2. The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation.
Chanpattana W; Chakrabhand ML; Kirdcharoen N; Tuntirungsee Y; Techakasem P; Prasertsuk Y
J Med Assoc Thai; 1999 Jun; 82(6):558-68. PubMed ID: 10443077
[TBL] [Abstract][Full Text] [Related]
3. Continuation electroconvulsive therapy in schizophrenia: a pilot study.
Chanpattana W
J Med Assoc Thai; 1997 May; 80(5):311-8. PubMed ID: 9175375
[TBL] [Abstract][Full Text] [Related]
4. Maintenance ECT in schizophrenia: a pilot study.
Chanpattana W
J Med Assoc Thai; 1998 Jan; 81(1):17-24. PubMed ID: 9470317
[TBL] [Abstract][Full Text] [Related]
5. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
[TBL] [Abstract][Full Text] [Related]
6. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
[TBL] [Abstract][Full Text] [Related]
7. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
8. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
[TBL] [Abstract][Full Text] [Related]
9. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.
Suzuki K; Awata S; Takano T; Ebina Y; Shindo T; Harada N; Matsuoka H
Psychiatry Clin Neurosci; 2006 Aug; 60(4):486-92. PubMed ID: 16884452
[TBL] [Abstract][Full Text] [Related]
10. [Electroconvulsive therapy and schizophrenia. Update from the data of the literature].
Joober R; Bennegadi Z; Olié JP; Lôo H
Encephale; 1991; 17(4):267-72. PubMed ID: 1683628
[TBL] [Abstract][Full Text] [Related]
11. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
[TBL] [Abstract][Full Text] [Related]
12. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R
Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694
[TBL] [Abstract][Full Text] [Related]
13. Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia.
Shimizu E; Imai M; Fujisaki M; Shinoda N; Handa S; Watanabe H; Nakazato M; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):571-3. PubMed ID: 17187911
[TBL] [Abstract][Full Text] [Related]
14. Maintenance ECT in treatment-resistant schizophrenia.
Chanpattana W
J Med Assoc Thai; 2000 Jun; 83(6):657-62. PubMed ID: 10932493
[TBL] [Abstract][Full Text] [Related]
15. DSM melancholic features are unreliable predictors of ECT response: a CORE publication.
Fink M; Rush AJ; Knapp R; Rasmussen K; Mueller M; Rummans TA; O'Connor K; Husain M; Biggs M; Bailine S; Kellner CH;
J ECT; 2007 Sep; 23(3):139-46. PubMed ID: 17804986
[TBL] [Abstract][Full Text] [Related]
16. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
Tang WK; Ungvari GS
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
[TBL] [Abstract][Full Text] [Related]
18. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
[TBL] [Abstract][Full Text] [Related]
19. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
[TBL] [Abstract][Full Text] [Related]
20. Are patients' attitudes towards and knowledge of electroconvulsive therapy transcultural? A multi-national pilot study.
Bustin J; Rapoport MJ; Krishna M; Matusevich D; Finkelsztein C; Strejilevich S; Anderson D
Int J Geriatr Psychiatry; 2008 May; 23(5):497-503. PubMed ID: 17997511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
